Exenatide Side Effects
Exenatide side effects include nausea (28%), vomiting (14%), and injection site nodules with Bydureon. What to know about the first-ever GLP-1 medication.
Nausea rate
28%
Injection nodules
10-15% (Bydureon)
Renal restriction
Contraindicated eGFR <30
Twice-daily GI
More frequent symptoms
CV safety
Non-inferior (EXSCEL)
Common Side Effects
Exenatide's side effect profile includes the typical GLP-1 gastrointestinal effects: nausea (28%), vomiting (14%), diarrhea (13%), dizziness (9%), headache (9%), dyspepsia (7%), and constipation (6%). These rates are comparable to other GLP-1 medications.
Byetta (twice daily) may cause more frequent but milder GI effects due to the twice-daily dosing cycle. Bydureon BCise (weekly) provides more consistent drug levels but can cause injection site reactions.
Bydureon-Specific Issues
Bydureon uses microsphere technology for sustained release, which can cause subcutaneous nodules at injection sites. These nodules are painless but can be cosmetically bothersome and may persist for weeks. Approximately 10-15% of patients experience noticeable injection site nodules.
Injection site itching, redness, and bruising also occur more frequently with Bydureon than with other weekly GLP-1 medications. Rotating injection sites helps minimize these effects.
Kidney Considerations
Exenatide is contraindicated in patients with severe renal impairment (eGFR <30) or end-stage renal disease. This is unique among GLP-1 medications and is due to exenatide's renal clearance pathway. Patients with moderate kidney disease (eGFR 30-50) should use exenatide with caution.
This renal restriction does not apply to semaglutide, tirzepatide, or dulaglutide, making those alternatives preferred for patients with kidney concerns.
Frequently Asked Questions
Why does Bydureon cause lumps?
Bydureon uses biodegradable microspheres for sustained drug release. These microspheres can form small subcutaneous nodules at the injection site that gradually dissolve over weeks. They're generally painless but can be noticeable.
Can exenatide affect kidneys?
Unlike newer GLP-1 medications, exenatide is cleared by the kidneys and is contraindicated in severe renal impairment (eGFR <30). If you have kidney concerns, semaglutide or tirzepatide are safer alternatives.
Explore safer and more effective GLP-1 alternatives
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Exenatide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.